A Boxed Warning explaining the risk of medication errors involving inadvertent neuraxial administration will be added to the labeling. The Food and Drug Administration (FDA) has issued an updated ...
Rapid Initiation Protocol Reduces Time to Treatment with SUBLOCADE® From One Week to One Hour, A Significant Advancement in the Treatment of Moderate to Severe Opioid Use Disorder (OUD) These FDA ...